Zusammenfassung
Obwohl der Primärtumor des Peniskarzinoms oft eine eindeutige Blickdiagnose darstellt, sollte immer eine histologische Sicherung vor der definitiven Therapie angestrebt werden. Die klinische Untersuchung soll das Ausmaß und die mögliche Infiltration von Schwellkörper und Urethra feststellen sowie die inguinalen Lymphknoten beurteilen. Eine präoperative Bildgebung der Primärläsion ist nur in unklaren Fällen indiziert. Das Lymphknotenmanagement ist der zentrale prognoseentscheidende Faktor. Kein bildgebendes Verfahren wie Sonographie, Computertomographie (CT), Magnetresonanztomographie (MRT) oder Positronenemissionstomographie (PET)/CT kann eine lymphogene Mikrometastasierung zuverlässig detektieren. Für alle Primärtumoren ab pT1G2 ist deshalb eine invasive Lymphknotendiagnostik notwendig. Die Heilungsrate kann bei entsprechender regelmäßiger Selbstuntersuchung bzw. im Rahmen der Vorsorge und der Nachsorge durch frühzeitige Diagnose und korrekte Therapie >90 % betragen, wobei oftmals Organerhalt möglich ist.
Abstract
Penile cancer is often an obvious visual diagnosis but histologic verification should be obtained prior to treatment. The clinical examination should determine the tumor stage and whether it has infiltrated the cavernous bodies and/or the urethra and it should adequately assess the inguinal lymph nodes. Preoperative imaging of the lesion is only indicated in equivocal cases. Curative treatment requires the complete removal of the primary tumor and all metastatic lymph nodes. Lymph node management is the key prognostic factor in the treatment of penile cancer. No imagining technique such as the ultrasound, CT, MRI or PET/CT is able to adequately detect micrometastatic lymph nodes. Therefore, invasive (inguinal) lymph node diagnosis is indicated for all tumour stages from pT1G2. Over 90% of penile cancer cases can be cured with early diagnosis and adequate treatment if routine self-examination and physical examinations are regularly performed.
Literatur
Parkin DM, Whelan SL, Ferlay J et al (2002) Cancer incidence in five continents. IARC scientific publications no. 155. IARC, Lyon
www.krebsgesellschaft.de. Zugegriffen: 15.01.2018
Zentrum für Krebsregisterfragen, Robert Koch-Institut (2017) Krebs – Datenbankabfrage. https://www.krebsdaten.de/Krebs/SiteGlobals/Forms/ErgebnisAnsicht/ErgebnisAnsicht_form.html. Zugegriffen: 15.01.2018
Tsen HF, Morgenstern H, Mack T, Peters RK (2001) Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (United States). Cancer Causes Control 12(3):267–277
Dillner J, Krogh G, Horenblas S, Meijer CJ (2000) Etiology of squamous cell carcinoma of the penis. Scand J Urol Nephrol Suppl 205:189–193
Schneede P, Schlenker B (2018) Humane Papillomaviren und Peniskarzinom. Überlegungen zu Präventionsmaßnahmen. Urologe. https://doi.org/10.1007/s00120-018-0597-3
Hakenberg OW, Prozel C (2017) Surgical treatment of metastatic penile cancer – what is the scientific rationale? Urologe A 56(5):624–626
Choo KJ, Ng SK, Sim CS, Cheng SW (2017) Pseudoepitheliomatous keratotic and micaceous balanitis treated with topical 5‑fluorouracil and liquid nitrogen. Clin Exp Dermatol. https://doi.org/10.1111/ced.13072
Cubilla AL, Dillner J, Schellhammer PF et al (2004) Tumours of the penis. In: Eble JN, Sauter G, Epstein JI, Sesterhenn ID (Hrsg) World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs. IARC Press, Lyon, S 280–290
Horenblas S et al (1993) Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes. J Urol 149:492
Protzel C, Hakenberg OW (2013) Penile carcinoma: diagnosis and therapy. Urologe A 52(1):87–98
Reddy JP, Pettaway CA, Lew LB, Pagliaro LC, Rao P, Javaratna I, Hoffmann KE (2017) Factors associated with regional recurence after lymph node dissection for penile squamous cell carcinoma. BJU Int 119(4):591–597
Horenblas S et al (1993) Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes. J Urol 149:492
Ornellas AA et al (1994) Surgical treatment of invasive squamous cell carcinoma of the penis: retrospective analysis of 350 cases. J Urol 151:1244
Zhu Y et al (2008) Predicting pelvic lymph node metastases in penile cancer patients: a comparison of computed tomography, Cloquet’s node, and disease burden of inguinal lymph nodes. Onkologie 31:37
Hakenberg OW, Comperat E, Minhas S, Necci A, Prozel C, Watkin N (2016) EAU guidelines on penile cancer 2016 (https://uroweb.org/guideline/penile-cancer/)
Krishna RP et al (2008) Sonography: an underutilized diagnostic tool in the assessment of metastatic groin nodes. J Clin Ultrasound 36:212
Mueller-Lisse UG et al (2008) Functional imaging in penile cancer: PET/computed tomography, MRI, and sentinel lymph node biopsy. Curr Opin Urol 18:105
Kayes O, Minhas S, Allen C et al (2007) The role of magnetic resonance imaging in the local staging of penile cancer. Eur Urol 51:1313–1318
Leijte JA et al (2009) Prospective evaluation of hybrid 18 F-fluorodeoxyglucose positron emission tomography/computed tomography in staging clinically node-negative patients with penile carcinoma. BJU Int 104:640
Schlenker B et al (2012) Detection of inguinal lymph node involvement in penile squamous cell carcinoma by 18F-fluorodeoxyglucose PET/CT: a prospective single-center study. Urol Oncol 30:55
Lützen U, Zuhayra M, Marx M, Colberg C, Knüpfer S, Baumann R, Kähler KC, Jünemann KP, Naumann CM (2016) Value and efficiency of sentinel lymph node diagnosis in patients with penile carcinoma with palpable inguinal lymph nodes as a new multimodal minimal invasive approach. Eur J Nucl Med Mol Imaging 43(13):2313–2323
Protzel C, Alcaraz A, Horenblas S et al (2009) Lymphadenectomy in the surcigal management of penile cancer. Eur Urol 55:1075–1088
Draeger DL, Heuschkel M, Protzel C, Erbersdobler A, Krause BJ, Hakenberg OW, Schwarzenböck SM (2017) The 18F-FDG-PET/CT for assessing inguinal lymph nodes metastases in patients with localized penile cancer – correlation with histopathology after inguinal lymphadenectomy. Nuklearmedizin 57. https://doi.org/10.3412/Nukmed-0932-17-10
Souillac I et al (2012) Prospective evaluation of (18)F-fluorodeoxyglucose positron emission tomography-computerized tomography to assess inguinal lymph node status in invasive squamous cell carcinoma of the penis. J Urol 187:493
Brierley JG et al (2016) TNM classification of malignant tumors, 8. Aufl. Wiley-Blackwell, Int. Union against Cancer, S 188–189
Ornellas AA et al (1994) Surgical treatment of invasive squamous cell carcinoma of the penis: retrospective analysis of 350 cases. J Urol 151:1244
Zhu Y et al (2008) Predicting pelvic lymph node metastases in penile cancer patients: a comparison of computed tomography, Cloquet’s node, and disease burden of inguinal lymph nodes. Onkologie 31:37
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
K.-D. Sievert, D.-L. Dräger, F.-M. Köhn, S. Milerski, C. Protzel und O.W. Hakenberg geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Sievert, KD., Dräger, DL., Köhn, FM. et al. Peniskarzinom: Diagnose und Staging. Urologe 57, 418–422 (2018). https://doi.org/10.1007/s00120-018-0602-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00120-018-0602-x